MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,908,469 | +42.8% | 388,165 | +18.4% | 0.00% | +100.0% |
| Q2 2023 | $11,841,823 | -17.5% | 327,756 | -15.1% | 0.00% | 0.0% |
| Q1 2023 | $14,360,775 | +4.6% | 386,250 | +27.4% | 0.00% | -50.0% |
| Q4 2022 | $13,734,277 | -82.9% | 303,118 | -73.7% | 0.00% | -77.8% |
| Q3 2022 | $80,379,000 | +559.9% | 1,150,889 | +534.3% | 0.01% | +800.0% |
| Q2 2022 | $12,181,000 | -23.2% | 181,455 | -5.9% | 0.00% | 0.0% |
| Q1 2022 | $15,856,000 | +52.0% | 192,844 | +171.1% | 0.00% | 0.0% |
| Q4 2021 | $10,434,000 | -53.6% | 71,138 | -44.1% | 0.00% | -50.0% |
| Q3 2021 | $22,502,000 | -36.7% | 127,193 | -42.2% | 0.00% | -50.0% |
| Q2 2021 | $35,574,000 | +39.4% | 220,231 | +47.8% | 0.00% | +33.3% |
| Q1 2021 | $25,520,000 | +24.4% | 148,979 | +59.5% | 0.00% | 0.0% |
| Q4 2020 | $20,520,000 | +26.0% | 93,430 | -4.7% | 0.00% | +50.0% |
| Q3 2020 | $16,286,000 | -4.1% | 98,083 | -34.0% | 0.00% | -33.3% |
| Q2 2020 | $16,977,000 | +48.2% | 148,700 | -0.3% | 0.00% | +50.0% |
| Q1 2020 | $11,459,000 | +89.1% | 149,081 | +216.9% | 0.00% | +100.0% |
| Q4 2019 | $6,061,000 | -11.9% | 47,041 | -46.8% | 0.00% | 0.0% |
| Q3 2019 | $6,882,000 | -39.1% | 88,346 | -19.5% | 0.00% | -50.0% |
| Q2 2019 | $11,298,000 | +58.6% | 109,686 | +12.9% | 0.00% | +100.0% |
| Q1 2019 | $7,125,000 | +325.4% | 97,196 | +146.1% | 0.00% | – |
| Q4 2018 | $1,675,000 | -13.9% | 39,498 | -4.4% | 0.00% | – |
| Q3 2018 | $1,946,000 | -52.8% | 41,318 | -50.6% | 0.00% | – |
| Q2 2018 | $4,127,000 | +4643.7% | 83,719 | +2848.9% | 0.00% | – |
| Q1 2018 | $87,000 | +690.9% | 2,839 | +373.2% | 0.00% | – |
| Q4 2017 | $11,000 | -65.6% | 600 | -77.8% | 0.00% | – |
| Q3 2017 | $32,000 | +18.5% | 2,700 | -63.9% | 0.00% | – |
| Q2 2017 | $27,000 | -38.6% | 7,483 | -12.5% | 0.00% | – |
| Q1 2017 | $44,000 | +91.3% | 8,548 | +77.7% | 0.00% | – |
| Q4 2016 | $23,000 | -4.2% | 4,811 | +33.9% | 0.00% | – |
| Q3 2016 | $24,000 | +300.0% | 3,594 | +236.8% | 0.00% | – |
| Q2 2016 | $6,000 | – | 1,067 | +7013.3% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 15 | -99.7% | 0.00% | – |
| Q4 2015 | $159,000 | -3.0% | 5,039 | +5.6% | 0.00% | – |
| Q3 2015 | $164,000 | -37.4% | 4,771 | -42.7% | 0.00% | – |
| Q2 2015 | $262,000 | +26100.0% | 8,323 | +37731.8% | 0.00% | – |
| Q1 2015 | $1,000 | -99.1% | 22 | -99.6% | 0.00% | – |
| Q2 2014 | $110,000 | – | 5,479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |